Publications

Association of Cerebrospinal Fluid Aβ1-42, t-tau, p-tau181, and α-synuclein Levels with Clinical Features of Early Drug Naïve Parkinson’s Disease Patients

Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, Waligorska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton A, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw LM and the Parkinson’s Progression Marker Initiative Investigators

Archives of Neurology. 2013; 70 (10) 1277-1287.

PubMed:

PMC4034348

Childhood and Adolescent Migraine Prevention (CHAMP) Study: A Double-Blinded, Placebo-Controlled, Comparative Effectiveness Study of Amitriptyline, Topiramate, and Placebo in the Prevention of Childhood and Adolescent Migraine

Hershey AD, Powers SW, Coffey CS, Ecklund D, Chamberlin LA, and Korbee LL on behalf of the CHAMP Study Group

Headache. 2013; 53 (5) 799-816.

PubMed:

PMC3637406

Effects of Blood Pressure Targets in Patients with Recent Lacunar Stroke

The SPS3 Investigators

Lancet. 2013; 382 (9891) 507-515.

PubMed:

PMC3979302

Monitoring Futility in a Two-by-Two Factorial Design: The SPS3 Experience

McClure LA, Coffey CS, and Howard GH

Clinical Trials. 2013; 10 (2) 250-256.

PubMed:

PMC3731445

Similar Blood Pressure Values Across Racial and Economic Groups: Baseline Data from a Group Randomized Trial

Carter BL, Coffey CS, Uribe L, James PA, Egan BM, Ardery G, Chrischilles EA, Ecklund D, VanderWeg M, and Vaughn T on behalf of the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) Trial Investigators

The Journal of Clinical Hypertension. 2013; 15 (6) 404-412.

PubMed:

PMC3683891